%0 Journal Article
%T A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, Cal-101 (GS-1101), in Combination with Rituximab and/or Bendamustine in Patients with Previously Treated, Indolent Non-Hodgkin Lymphoma (iNHL)
%A de Vos, Sven
%A Schreeder, Marshall T.
%A Flinn, Ian W.
%A Coutre, Steven E.
%A Leonard, John P.
%A Wagner-Johnston, Nina D.
%A Fowler, Nathan H.
%A Boccia, Ralph V.
%A Barrientos, Jaqueline C.
%A Boyd, Thomas
%A Sharman, Jeff
%A Holes, Leanne
%A Lannutti, Brian
%A Johnson, Dave M.
%A Jahn, Thomas M.
%A Miller, Langdon L
%A ,
%J Blood
%V 118
%N 21
%P 2699-2699
%@ 0006-4971
%D 2011-11-18
%I American Society of Hematology
%~ DeepDyve